Revvity, Inc.
Revvity, Inc. (RVTY) Financial Performance & Income Statement Overview
Review Revvity, Inc. (RVTY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revvity, Inc. (RVTY) Income Statement & Financial Overview
Review Revvity, Inc. RVTY income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $664.76M | $729.37M | $684.05M | $691.68M |
| Cost of Revenue | $289.22M | $317.08M | $299.23M | $306.18M |
| Gross Profit | $375.55M | $412.29M | $384.82M | $385.51M |
| Gross Profit Ratio | $0.56 | $0.57 | $0.56 | $0.56 |
| R&D Expenses | $53.60M | $49.21M | $49.14M | $48.13M |
| SG&A Expenses | $249.72M | $245.04M | $237.52M | $251.65M |
| Operating Expenses | $303.32M | $293.54M | $286.67M | $299.78M |
| Total Costs & Expenses | $592.53M | $610.62M | $585.90M | $605.96M |
| Interest Income | $10.08M | $9.83M | $22.76M | $20.51M |
| Interest Expense | $22.96M | $22.78M | $24.38M | $24.72M |
| Depreciation & Amortization | $97.42M | $105.03M | $107.67M | $107.34M |
| EBITDA | $172.77M | $223.07M | $232.41M | $218.62M |
| EBITDA Ratio | $0.26 | $0.31 | $0.34 | $0.32 |
| Operating Income | $72.23M | $118.75M | $98.15M | $85.72M |
| Operating Income Ratio | $0.11 | $0.16 | $0.14 | $0.12 |
| Other Income/Expenses (Net) | -$19.85M | -$24.19M | $2.21M | $938000.00 |
| Income Before Tax | $52.38M | $94.56M | $100.36M | $86.66M |
| Income Before Tax Ratio | $0.08 | $0.13 | $0.15 | $0.13 |
| Income Tax Expense | $10.71M | $6.17M | $6.97M | $14.06M |
| Net Income | $42.24M | $94.64M | $94.37M | $55.36M |
| Net Income Ratio | $0.06 | $0.13 | $0.14 | $0.08 |
| EPS | $0.35 | $0.78 | $0.77 | $0.45 |
| Diluted EPS | $0.35 | $0.78 | $0.77 | $0.45 |
| Weighted Avg Shares Outstanding | $120.14M | $120.65M | $122.81M | $123.35M |
| Weighted Avg Shares Outstanding (Diluted) | $120.23M | $121.58M | $123.03M | $123.48M |
Over the past four quarters, Revvity, Inc. demonstrated steady revenue growth, increasing from $691.68M in Q2 2024 to $664.76M in Q1 2025. Operating income reached $72.23M in Q1 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $172.77M, reflecting operational efficiency. Net income dropped to $42.24M, with EPS at $0.35. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan